Mahmoud E. S. Soliman
Orcid: 0000-0002-8711-7783
According to our database1,
Mahmoud E. S. Soliman
authored at least 11 papers
between 2013 and 2023.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
On csauthors.net:
Bibliography
2023
Halting aberrant DNA methylation via <i>in silico</i> Identification of potent inhibitors of DNMT3B enzyme: Atomistic insights.
Comput. Biol. Chem., August, 2023
2021
Distinguishing the optimal binding mechanism through reversible and irreversible inhibition analysis of HSP72 protein in cancer therapy.
Comput. Biol. Medicine, 2021
Could chroman-4-one derivative be a better inhibitor of PTR1? - Reason for the identified disparity in its inhibitory potency in <i>Trypanosoma brucei</i> and <i>Leishmania major</i>.
Comput. Biol. Chem., 2021
Atomistic insights into the selective therapeutic activity of 6-(2, 4-difluorophenoxy)-5-((ethylmethyl)pyridine-3-yl)-8-methylpyrrolo[1, 2-<i>a</i>]pyrazin-1(2H)-one towards bromodomain-containing proteins.
Comput. Biol. Chem., 2021
2020
Computational and drug target analysis of functional single nucleotide polymorphisms associated with Haemoglobin Subunit Beta (<i>HBB</i>) gene.
Comput. Biol. Medicine, 2020
Triple <i>Mycobacterial</i> ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives.
Comput. Biol. Chem., 2020
2019
From genomic variation to protein aberration: Mutational analysis of single nucleotide polymorphism present in <i>ULBP6</i> gene and implication in immune response.
Comput. Biol. Medicine, 2019
Drug promiscuity: Exploring the polypharmacology potential of 1, 3, 6-trisubstituted 1, 4-diazepane-7-ones as an inhibitor of the 'god father' of immune checkpoint.
Comput. Biol. Chem., 2019
2018
Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer's disease using bioinformatics and computational tools.
Comput. Biol. Medicine, 2018
Allosteric inhibition abrogates dysregulated LFA-1 activation: Structural insight into mechanisms of diminished immunologic disease.
Comput. Biol. Chem., 2018
2013
Molecular modelling studies of synthesized pentacyclo-undecane peptides as potential HIV-1 wild type C-SA protease inhibitors.
J. Cheminformatics, 2013